126 related articles for article (PubMed ID: 22747472)
21. Prevalence and immunohistochemical findings of subclinical kidney allograft rejection and its association with graft outcome.
Veronese FV; Noronha IL; Manfro RC; Edelweiss MI; Goldberg J; Gonçalves LF
Clin Transplant; 2004 Aug; 18(4):357-64. PubMed ID: 15233810
[TBL] [Abstract][Full Text] [Related]
22. Acute rejection in non-compliant renal allograft recipients: a distinct morphology.
Lerut E; Kuypers DR; Verbeken E; Cleutjens J; Vlaminck H; Vanrenterghem Y; Van Damme B
Clin Transplant; 2007; 21(3):344-51. PubMed ID: 17488383
[TBL] [Abstract][Full Text] [Related]
23. Plasma pentraxin-3 as a marker of bioincompatibility in hemodialysis patients.
Oldani S; Finazzi S; Bottazzi B; Garlanda C; Baldassarre E; Valaperta S; Cuccovillo I; Albini M; Child M; Montanelli A; Graziani G; Badalamenti S
J Nephrol; 2012; 25(1):120-6. PubMed ID: 21725917
[TBL] [Abstract][Full Text] [Related]
24. Osteopontin level correlates with acute cellular renal allograft rejection.
Wang J; Tang Q; Qiu Y; Xu M; Rong R; Zhu T
J Surg Res; 2013 Jun; 182(1):161-5. PubMed ID: 22947699
[TBL] [Abstract][Full Text] [Related]
25. Surveillance biopsies are superior to functional studies for the diagnosis of acute and chronic renal allograft pathology in children.
Birk PE; Stannard KM; Konrad HB; Blydt-Hansen TD; Ogborn MR; Cheang MS; Gartner JG; Gibson IW
Pediatr Transplant; 2004 Feb; 8(1):29-38. PubMed ID: 15009838
[TBL] [Abstract][Full Text] [Related]
26. Osteopontin expression in acute renal allograft rejection.
Alchi B; Nishi S; Kondo D; Kaneko Y; Matsuki A; Imai N; Ueno M; Iguchi S; Sakatsume M; Narita I; Yamamoto T; Gejyo F
Kidney Int; 2005 Mar; 67(3):886-96. PubMed ID: 15698428
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction.
Latini R; Maggioni AP; Peri G; Gonzini L; Lucci D; Mocarelli P; Vago L; Pasqualini F; Signorini S; Soldateschi D; Tarli L; Schweiger C; Fresco C; Cecere R; Tognoni G; Mantovani A;
Circulation; 2004 Oct; 110(16):2349-54. PubMed ID: 15477419
[TBL] [Abstract][Full Text] [Related]
28. Transcriptome changes in renal allograft protocol biopsies at 3 months precede the onset of interstitial fibrosis/tubular atrophy (IF/TA) at 6 months.
Scherer A; Gwinner W; Mengel M; Kirsch T; Raulf F; Szustakowski JD; Hartmann N; Staedtler F; Engel G; Klupp J; Korn A; Kehren J; Haller H
Nephrol Dial Transplant; 2009 Aug; 24(8):2567-75. PubMed ID: 19398767
[TBL] [Abstract][Full Text] [Related]
29. The clinical and pathologic implications of plasmacytic infiltrates in percutaneous renal allograft biopsies.
Meehan SM; Domer P; Josephson M; Donoghue M; Sadhu A; Ho LT; Aronson AJ; Thistlethwaite JR; Haas M
Hum Pathol; 2001 Feb; 32(2):205-15. PubMed ID: 11230708
[TBL] [Abstract][Full Text] [Related]
30. Pentraxin 3 in plasma and vaginal fluid in women with preterm delivery.
Assi F; Fruscio R; Bonardi C; Ghidini A; Allavena P; Mantovani A; Locatelli A
BJOG; 2007 Feb; 114(2):143-7. PubMed ID: 17305891
[TBL] [Abstract][Full Text] [Related]
31. Pentraxin-3 as a marker of disease activity in Takayasu arteritis.
Dagna L; Salvo F; Tiraboschi M; Bozzolo EP; Franchini S; Doglioni C; Manfredi AA; Baldissera E; Sabbadini MG
Ann Intern Med; 2011 Oct; 155(7):425-33. PubMed ID: 21969341
[TBL] [Abstract][Full Text] [Related]
32. Long pentraxin 3 (PTX3) expression and release by neutrophils in vitro and in ulcerative colitis.
Savchenko AS; Inoue A; Ohashi R; Jiang S; Hasegawa G; Tanaka T; Hamakubo T; Kodama T; Aoyagi Y; Ushiki T; Naito M
Pathol Int; 2011 May; 61(5):290-7. PubMed ID: 21501295
[TBL] [Abstract][Full Text] [Related]
33. The long pentraxin 3 is a soluble and cell-associated component of the human semen.
Doni A; Paffoni A; Nebuloni M; Ragni G; Pasqualini F; Valentino S; Bonetti S; Mantovani A; Somigliana E; Garlanda C
Int J Androl; 2009 Jun; 32(3):255-64. PubMed ID: 18179560
[TBL] [Abstract][Full Text] [Related]
34. Immunoexpression of perforin and granzyme B on infiltrating lymphocytes in human renal acute allograft rejection.
Wagrowska-Danilewicz M; Danilewicz M
Nefrologia; 2003; 23(6):538-44. PubMed ID: 15002789
[TBL] [Abstract][Full Text] [Related]
35. Plasma pentraxin 3 may be a better marker of peripheral artery disease in hemodialysis patients than C-reactive protein.
Zhou Y; Ni Z; Zhang J; Zhang W; Wu Q; Shen G; Wang Y; Qian J
Vasc Med; 2013 Apr; 18(2):85-91. PubMed ID: 23609129
[TBL] [Abstract][Full Text] [Related]
36. Impact of CMV infection on acute rejection and long-term renal allograft function: a systematic analysis in patients with protocol biopsies and indicated biopsies.
Erdbruegger U; Scheffner I; Mengel M; Schwarz A; Verhagen W; Haller H; Gwinner W
Nephrol Dial Transplant; 2012 Jan; 27(1):435-43. PubMed ID: 21712490
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of cytotoxic T-lymphocytes and CD40 in biopsies with early renal allograft rejection.
Mengel M; Mueller I; Behrend M; von Wasielewski R; Radermacher J; Schwarz A; Haller H; Kreipe H
Transpl Int; 2004 Jul; 17(6):293-300. PubMed ID: 15221125
[TBL] [Abstract][Full Text] [Related]
38. Apoptotic tubular cell death during acute renal allograft rejection.
Wever PC; Aten J; Rentenaar RJ; Hack CE; Koopman G; Weening JJ; ten Berge IJ
Clin Nephrol; 1998 Jan; 49(1):28-34. PubMed ID: 9491283
[TBL] [Abstract][Full Text] [Related]
39. Plasma pentraxin 3 is associated with cardiovascular disease in hemodialysis patients.
Xu Y; Ding X; Zou J; Liu Z; Jiang S; Xu S; Shen B; Chen Y; Shan Y; Cao X
Ren Fail; 2011; 33(10):998-1004. PubMed ID: 22013933
[TBL] [Abstract][Full Text] [Related]
40. Pancreas allograft rejection: analysis of concurrent renal allograft biopsies and posttherapy follow-up biopsies.
Troxell ML; Koslin DB; Norman D; Rayhill S; Mittalhenkle A
Transplantation; 2010 Jul; 90(1):75-84. PubMed ID: 20548259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
